中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Xiaxia YU)

1.Pharmacokinetics of dimemorfan phosphate foIIowing singIe and muItipIe-dose oraI administration in heaIthy Chinese voIunteers

Xiaxia YU ; Jinfeng FU ; Hui ZHAO ; Yuan TIAN ; Zunjian ZHANG

Journal of China Pharmaceutical University 2016;(1):73-78

2.Metabolic profiling of the nephrotoxicity of realgar nanoparticles in rats

Xiaxia YU ; Shaoyuan LI ; Yunfei HUA ; Yiwei LYU ; Mohan ZHANG ; Yin HUANG

Journal of China Pharmaceutical University 2017;48(3):328-333

3.Combined therapy of super-pulsed CO2 laser and traditional Chinese medicine for prevention and treatment of post-traumatic hypertrophic scar

Dan YAN ; Zechun HUANG ; Hui LI ; Han YU ; Anli ZHANG ; Zhiwei LIANG ; Hongmei WANG ; Li PENG ; Xiaxia LI

Chinese Journal of Medical Aesthetics and Cosmetology 2010;16(5):317-319

4.Simultaneous Determination of Seven B Vitamins in Rat Plasma by High-performance Liquid Chromatography-tandem Mass Spectrometry

Xiaxia YU ; Yutong ZENG ; Jiahong YANG ; Jing WU ; Yan XU ; Yin HUANG

Herald of Medicine 2023;42(12):1796-1801

5.Non-targeted LC-MS profiling reveals association between human early embryo grades and levels of amino acids and carnitines in embryo culture medium

Wen LI ; Xiangyu ZHAO ; Wei DONG ; Cunfei LIU ; Xiaxia LIU ; Hongyan XU ; Zhaopeng YU ; Hui LIU ; Chunhai GAO

Chinese Journal of Laboratory Medicine 2023;46(5):458-463

6.Prevention effect of lower extremity deep venous thrombosis with A-V impulse foot pump for patients who took spinal surgery

Xueqin DING ; Shoumei YU ; Xiaxia JIANG ; Ru ZOU ; Shuyu WANG ; Huimin WANG ; Hong LIU

Chinese Journal of Practical Nursing 2017;33(25):1952-1955

7. Research progress in population pharmacokinetics of rituximab

Mengxue LI ; Jie HE ; Xiaxia YU ; Linlin HU ; Hua SHAO ; Linlin HU

Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(4):468-474

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO